Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abrdn plc boosted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 7.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 68,620 shares of the medical research company’s stock after purchasing an additional 4,643 shares during the quarter. abrdn […]
Banque Pictet & Cie SA lifted its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 295,013 shares of the medical research company’s stock after purchasing an additional 2,287 shares […]
Banque Pictet & Cie SA grew its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 295,013 shares of the medical research company’s stock after purchasing an additional 2,287 shares during the […]
Steel Peak Wealth Management LLC decreased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 76.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,332 shares of the medical research company’s stock after selling 14,187 shares during […]
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12-month price […]